Use biologic agents to induce remission in patients with moderately severe...
Bethesda, MD A-The anti-TNF-I biologic agents, such as infliximab or adalimumab, are recommended to induce remission in patients with moderately severe Crohn's disease , according to a new guideline...
View ArticleAllopurinol use in pregnancy in three women with inflammatory bowel...
Allopurinol is a frequently prescribed drug. In inflammatory bowel disease patients who shunt thiopurine metabolism towards more toxic and less desirable pathways, allopurinol is proving to be an...
View Articleкто знает хорошего иммунолога ?
Привет всем!!)Ребят,кто знает хорошего иммунолога?Если знаете напишите его телефон!Буду очень вам благодарен!!):rolleyes:
View ArticleЧто вам не нравится и что нравится в кошках?
Мама миа! Итальяно писсуаро! - закричал кот, увидев в коридоре новые итальянские туфли. Вот интересно, а что ваша кошка делает такого, за что вы готовы ее наказать? Наша: охотилась на попугая - но это...
View ArticleМёд с корицей при НЯК??
Привет всем!!Что Вы думаете о том что бы вместо сахара добавлять мёд?Ну и просто пить мёд с корицей при НЯК??:confused:
View ArticleBiogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe
Biogen Idec and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has exercised its right to enter into an agreement to commercialize anti-TNF biosimilar product candidates in...
View Article5 дизайнерских проектов, на создание которых требуется менее 5 минут
Пьер Лота (Pierre Lota) — дизайнер и лайфхакер со стажем. Он создаёт невероятные вещи из обычных подручных средств: коробок из-под обуви, куска пластмассового листа, бумаги, картона… Повторить его...
View ArticleCancer risk in IBD according to patient phenotype and treatment
A study in December's issue of the American Journal of Gastroenterology examines the risk of cancer IBD according to patient phenotype and treatment. More...
View ArticleCrohna s Disease
Crohn's disease is a type of inflammatory bowel disease that affects the tissues of the gastrointestinal tract. More...
View ArticleSt Helens Star: - Thomas was a gentle young man and he had a lovely smile'
A HEARTBROKEN father has described his utter devastation and shock after his 15-year-old son died from suspected sudden death syndrome. More...
View ArticleInflammatory Bowel Disease: Nuances of Drug Therapy in Seniors and the Role...
Recipient of the Excellence in Geriatric Pharmacy Practice Award from the Commission for Certification in Geriatric Pharmacy. More...
View ArticleCoronado Biosciences Says Drug That Failed In Crohn's Disease May Work In Autism
Coronado Biosciences is betting that a drug made from the tiny eggs of a worm found inside the intestines of a pig - which two months ago failed in a trial in patients with Crohn's disease - might be...
View ArticleTakeda Announces Exclusive License and Option Agreement with Natrogen ...
OSAKA, Japan & DEERFIELD, Ill. & NEW YORK -- -- Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will...
View ArticleNovel biomarkers for Crohn's disease activity
Dr William Faubion and colleagues from Minnesota, USA investigates biomarkers reflective of mucosal and bowel wall inflammation would be useful to monitor disease activity. More...
View ArticlePossible therapeutic role of vitamin D in IBD
Drs Mouli and Ananthakrishnan from Massachussetts, USA reviewed the evidence supporting a role of vitamin D in inflammatory bowel diseases. More...
View ArticleNew mechanism revealed for arthritis progression
University of Utah researchers have discovered a naturally occurring genetic variation in mice that predisposes carriers toward developing severe, inflammatory arthritis. The finding implicates a new...
View ArticleAthersys Confirms Completion of Patient Enrollment of Pfizer's Phase...
The study is a randomized, double-blind, placebo-controlled, multi-center clinical trial evaluating the safety and efficacy of MultiStem therapy in subjects with moderate to severe ulcerative colitis....
View ArticleFirst treatment for infants with CAPS licensed in UK
Anakinra (Kineret®), an interleukin-1 (IL-1) inhibitor, has been granted a licence for treatment of CAPS in children and adults by the Medicines and Healthcare Products Regulatory Agency...
View Article